| Offering Information |
| Expected Date | 2013 |
| Proposed Exchange/Ticker |
Nasdaq: HART |
| Security Type |
Common Stock |
| Lead Underwriter |
Summer Street Research Partner Maxim Group LLC |
| Days In Registration |
- |
| Date Filed |
11-Dec-2012 |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2012) |
| Industry |
Manufacturing |
| Business Description |
Harvard Apparatus Regenerative Technology Inc, based in Holliston, Massachusetts, is a clinical stage regenerative medicine company developing life-saving medical devices. Its products were bioreactor and a synthetic scaffold that can be used by surgeons to create a replacement trachea, or airway, for patients who need an airway transplant. It is a wholly-owned subsidiary of Harvard Bioscience Inc. The company was incorporated under the laws of the State of Delaware on May 3, 2012. |
| Revenue |
- |
| Net Income |
- |
| Shares Outstanding (post-offering) |
8.0M |
| Contact |
- |
| Number of Employees |
- |
|
| Original Filing Information |
| US |
| Shares Filed |
- |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
- |
| · As a Percent |
- |
| Overallotment Shares Filed |
- |
| File Amount |
$20.0M |
| File Price Range |
- - - |
| File Mid Price |
- |
|
